524572 PHARMAID

Pharmaids Pharmaceuticals Share Price

₹63.94 +3.04 (4.99%)

29 Dec, 2024 07:13

SIP TrendupStart SIP in PHARMAID

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -10.36%
  • Over 3 Month + 61.59%
  • Over 6 Month + 28.14%
  • Over 1 Year + 37.89%
SIP Lightning

Smart Investing Starts Here Start SIP with Pharmaids Pharmaceuticals for Steady Growth!

Invest Now

Pharmaids Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Pharmaids Pharmaceuticals Financials

Pharmaids Pharmaceuticals Technicals

EMA & SMA

Current Price
₹63.94
+ 3.04 (4.99%)
pointer
  • stock-down_img
  • Bullish Moving Average 15
  • stock-up_img
  • Bearish Moving Average 1
  • 20 Day
  • ₹60.82
  • 50 Day
  • ₹58.47
  • 100 Day
  • ₹54.60
  • 200 Day
  • ₹51.40

Resistance and Support

63.93 Pivot Speed
  • R3 63.99
  • R2 63.97
  • R1 63.95
  • S1 63.91
  • S2 63.89
  • S3 63.87

What's your outlook on Pharmaids Pharmaceuticals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Pharmaids Pharms. has an operating revenue of Rs. 15.74 Cr. on a trailing 12-month basis. Pre-tax margin of -103% needs improvement, ROE of -11% is poor and needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 76 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Pharmaids Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-05-28 Audited Results
2024-02-12 Quarterly Results
2024-01-06 Preferential issue of shares
2023-11-11 Quarterly Results

Pharmaids Pharmaceuticals F&O

Pharmaids Pharmaceuticals Shareholding Pattern

5.19%
41.03%
53.78%

About Pharmaids Pharmaceuticals

  • NSE Symbol
  • PHARMAID
  • BSE Symbol
  • 524572
  • ISIN
  • INE117D01018

Similar Stocks to Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals FAQs

Pharmaids Pharmaceuticals share price is ₹63 As on 29 December, 2024 | 06:59

The Market Cap of Pharmaids Pharmaceuticals is ₹225.5 Cr As on 29 December, 2024 | 06:59

The P/E ratio of Pharmaids Pharmaceuticals is -18.7 As on 29 December, 2024 | 06:59

The PB ratio of Pharmaids Pharmaceuticals is 3.2 As on 29 December, 2024 | 06:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23